Ying Huang
Stock Analyst at B of A Securities
(2.35)
# 2,520
Out of 4,876 analysts
39
Total ratings
50%
Success rate
9.18%
Average return
Main Sectors:
Stocks Rated by Ying Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $555 → $567 | $441.30 | +28.48% | 14 | Mar 31, 2025 | |
| GILD Gilead Sciences | Maintains: Neutral | $70 → $72 | $110.67 | -34.94% | 8 | Feb 5, 2020 | |
| RDUS Radius Recycling | Maintains: Buy | $51 → $47 | $29.64 | +58.57% | 1 | Jul 25, 2018 | |
| RGNX REGENXBIO | Downgrades: Neutral | $64 → $80 | $8.39 | +853.52% | 3 | Jul 23, 2018 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | n/a | $0.99 | - | 2 | May 2, 2018 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $34 → $40 | $2.25 | +1,677.78% | 2 | Mar 8, 2018 | |
| PBYI Puma Biotechnology | Maintains: Buy | $135 → $115 | $3.33 | +3,353.45% | 2 | Jan 24, 2018 | |
| IRWD Ironwood Pharmaceuticals | Downgrades: Underperform | n/a | $0.72 | - | 4 | Jan 5, 2018 | |
| BIIB Biogen | Maintains: Buy | $358 → $365 | $126.08 | +189.50% | 1 | Oct 18, 2017 | |
| BOLD Boundless Bio | Maintains: Buy | $23 → $33 | $1.01 | +3,167.33% | 1 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $277.13 | - | 1 | Feb 1, 2017 |
Vertex Pharmaceuticals
Mar 31, 2025
Maintains: Buy
Price Target: $555 → $567
Current: $441.30
Upside: +28.48%
Gilead Sciences
Feb 5, 2020
Maintains: Neutral
Price Target: $70 → $72
Current: $110.67
Upside: -34.94%
Radius Recycling
Jul 25, 2018
Maintains: Buy
Price Target: $51 → $47
Current: $29.64
Upside: +58.57%
REGENXBIO
Jul 23, 2018
Downgrades: Neutral
Price Target: $64 → $80
Current: $8.39
Upside: +853.52%
Esperion Therapeutics
May 2, 2018
Downgrades: Underperform
Price Target: n/a
Current: $0.99
Upside: -
CytomX Therapeutics
Mar 8, 2018
Maintains: Buy
Price Target: $34 → $40
Current: $2.25
Upside: +1,677.78%
Puma Biotechnology
Jan 24, 2018
Maintains: Buy
Price Target: $135 → $115
Current: $3.33
Upside: +3,353.45%
Ironwood Pharmaceuticals
Jan 5, 2018
Downgrades: Underperform
Price Target: n/a
Current: $0.72
Upside: -
Biogen
Oct 18, 2017
Maintains: Buy
Price Target: $358 → $365
Current: $126.08
Upside: +189.50%
Boundless Bio
Sep 22, 2017
Maintains: Buy
Price Target: $23 → $33
Current: $1.01
Upside: +3,167.33%
Feb 1, 2017
Upgrades: Buy
Price Target: n/a
Current: $277.13
Upside: -